Full Text View
Tabular View
Study Results
Related Studies
Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
This study has been completed.
Study NCT00992836   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on October 8, 2009.   Last Updated on September 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
H1N1 Influenza Virus
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Influenza, Human
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services